	Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens. Cancer Cell Int Zhang MY, Xiao F, Li ZH, Huang HH. PMID: 41943110 [PubMed - as supplied by publisher]
	Multiple presentations: a single pathology, primary central nervous system lymphoma (PCNSL). A multicenter study. J Neurooncol González-Aguilar A, Jiménez-Quintero A, Díaz-Alba A, Macías-Arriaga G, Cacho-Díaz B, Reyes-Moreno I, Gutiérrez-Aceves GA, García-González U, Guerrero-Juárez V, Manuel de Jesús ER, Antonio-Heredia Á, Zertuche-Ortuño L, Soto GR, Hernández GH, Gutiérrez-Casillas S. PMID: 41942762 [PubMed - in process]
	CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients. Blood Cancer J Fathima S, Rokach L, Ghosoun N, Rezasoltani M, Ilyas R, Alsugair A, McCullough K, Abdelmagid M, Al-Kali A, Alkhateeb HB, Begna KH, Mangaonkar AA, Matin A, Saliba AN, Hefazi Torghabeh M, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Badar T, Murthy H, Foran J, Palmer J, Punwani N, Sproat L, Khera N, Arana Yi C, Tefferi A, Gangat N. PMID: 41942467 [PubMed - as supplied by publisher]
	Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical Experience. Eur J Haematol Bonello F, Aroldi A, Castellino A, Mannelli L, Boccellato E, Rosati S, Verga L, Vitolo U. PMID: 41942142 [PubMed - as supplied by publisher]
	First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia. J Clin Oncol Rettinger E, Heckl D, Hutter M, Salzmann-Manrique E, Luedtke M, Huenecke S, Bremm M, Cappel C, Bug G, Greil J, Meisel R, Wagner-Drouet EM, Serve H, Güngör T, Klusmann JH, Klingebiel T, Bader P, Bonig H. PMID: 41941697 [PubMed - as supplied by publisher]
	Phase 1 Study of KITE-222, an Autologous CLL-1-directed CAR T-cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia. Clin Cancer Res Daver N, Blachly JS, Ghobadi A, Advani A, Muffly L, Garciaz S, Recher C, Kahali B, Sun J, Jung AS, Filosto S, Mao D, Granados E, Sallman DA. PMID: 41941266 [PubMed - as supplied by publisher]
	Efficacy and safety of zanubrutinib and camrelizumab combined with CD19 chimeric antigen receptor T-cell in the treatment of relapsed/refractory diffuse large B-cell lymphoma. Front Immunol Zhang H, He X, Xiao X, Ly H, Zhao M. PMID: 41939901 [PubMed - indexed for MEDLINE]
	Prognostic factors in SÃ©zary syndrome - a retrospective propensity score-matched study on 1277 patients. Front Immunol Ninosu N, Kappenstein M, Gebauer N, von Bubnoff D, von Bubnoff N, Nicolay JP. PMID: 41939895 [PubMed - indexed for MEDLINE]
	Correction to "Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry". Hemasphere PMID: 41939252 [PubMed]
	Enhancing Immunotherapy in Diffuse Large B-Cell Lymphoma: The Synergistic Potential of Metabolic Checkpoint Inhibitors and Immunomodulation. Onco Targets Ther Rajendraprasad MK, Riches JC. PMID: 41938476 [PubMed]
	Preoperative diagnosis of a recurrent anaplastic lymphoma kinase-negative inflammatory myofibroblastic tumor of the sigmoid colon using EUS-guided fine-needle aspiration: A case report. Endosc Ultrasound Xie N, Cheng Y, Wu T, Miao L, Kang Z, Shi H. PMID: 41938142 [PubMed]
	Vanishing bone metastasis in pediatric mediastinal lymphoma: A diagnostic pitfall on contrast-enhanced computed tomography. Radiol Case Rep Rania B, Lina B, Ouiam T, Nazik A, Latifa C, Sihame EH. PMID: 41937802 [PubMed]
	Increasing incidence and changing distribution of primary cancers in therapy-related acute myeloid leukemia: A population-based study in Osaka, Japan, 1990-2020. Cancer Kishimoto K, Nakata K, Kato MS, Ikawa T, Kudo H, Iwaki Y, Kuwabara Y, Morishima T, Miyashiro I. PMID: 41937496 [PubMed - indexed for MEDLINE]
	Neurotoxicity in older patients with relapsed or refractory large B-cell lymphoma treated with CAR T-cell therapy: A multicenter study. Transplant Cell Ther Tun AM, Patel R, St-Pierre F, Ouchveridze J, Niu A, Thordardottir T, Obasi J, Rosenthal A, Pophali PA, Fenske T, Karmali R, Johnston PB, Ahmed S. PMID: 41935576 [PubMed - as supplied by publisher]
	Targeting PI3KÎ´ for lymphoma and immune diseases treatment: a review. Mol Divers Jia W. PMID: 41934567 [PubMed - as supplied by publisher]
	Plasmablastic lymphoma with uncommon MYC::IGH gene rearrangement: a diagnostic and molecular dilemma. Int J Hematol Sarrafan-Chaharsoughi Z, Strange T, Chea MR, Ovechko V, Lyapichev K, Aakash F. PMID: 41934552 [PubMed - as supplied by publisher]
	miR-193-5p, miR-1307-5p, and miR-671-5p: Potential biomarkers for chemoresistance in diffuse large B-cell lymphoma. Indian J Med Res Sharma A, Das A, Bal A, Srinivasan R, Malhotra P, Prakash G, Kumar R. PMID: 41934430 [PubMed - indexed for MEDLINE]
	Current Treatment of Double Refractory Chronic Lymphocytic Leukemia: A Focus on Novel Drugs. Clin Lymphoma Myeloma Leuk Jain E, Sainatham C, Raghavan P, Jain A, Lutfi F. PMID: 41934060 [PubMed - as supplied by publisher]
	Diagnostic Value of Nucleated Red Blood Cells in Pediatric Acute Lymphoblastic Leukemia. Clin Pediatr (Phila) Ay Tuncel D, Seringec Akkececi N, Acipayam C. PMID: 41933484 [PubMed - as supplied by publisher]
	Fatal invasive Trichosporon asahii infection with exophytic bronchial lesions in a patient with lymphoma undergoing CAR T-cell therapy. BMJ Case Rep Paramythiotou E, Pappa E, Iliadi V, Vernikos P. PMID: 41932713 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 166964

Page 1 of 8349



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy